Share

Emergent Biosolutions CEO talks production of Johnson & Johnson vaccine

Emergent Biosolutions last year signed a multi-year agreement with the U.S. and Johnson & Johnson to handle domestic manufacturing of a Covid-19 vaccine. CEO Bob Kramer gives an update on the effort.
02:47
Wed, Mar 3 20217:08 PM EST